AbbVie Inc (TSX:ABBV)
C$ 35.51 -1.4 (-3.79%) Market Cap: 592.81 Bil Enterprise Value: 683.00 Bil PE Ratio: 123.73 PB Ratio: 0 GF Score: 81/100

AbbVie Inc at JPMorgan Healthcare Conference Transcript

Jan 14, 2026 / 04:15PM GMT
Release Date Price: C$31.26 (+0.61%)
Christopher Schott
JPMorgan Chase & Co - Analyst

Good morning, everybody. I'm Chris Schott at JPMorgan and it's my pleasure to be hosting this fireside chat today with AbbVie. From the company, we have Scott Reents, CFO; Jeff Stewart, Chief Commercial Officer; and Roopal Thakkar, Chief Medical Officer.

So Happy New Year, guys and thanks for joining today.

Questions & Answers

Christopher Schott
JPMorgan Chase & Co - Analyst

I'd like just to kick off the conversation, Scott, as we enter 2026, can you just run through top priorities for AbbVie and how you're thinking about the business?

Scott Reents
AbbVie Inc - Chief Financial Officer, Executive Vice President

Sure. Great. Thanks for having us, Chris. We're very excited to be here today and to talk about AbbVie.

So when we look at 2026, I would say it's really a continuation of the strategy that we've been articulating. One is just to operate and execute operationally in a way that delivers strong financial results and then

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot